Trade CNS Pharmaceuticals, Inc. - CNSP CFD
What is CNS Pharmaceuticals, Inc. (CNSP)?
CNS Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing treatments for central nervous system cancers. The company focuses on therapies targeting brain tumors and other neurological malignancies. CNS Pharmaceuticals utilizes drug delivery technologies designed to enhance the penetration of therapeutic agents across the blood-brain barrier. Its research and development efforts include small molecule drugs and other modalities aimed at improving efficacy and safety profiles. The company conducts clinical trials to evaluate the therapeutic potential of its candidates. CNS Pharmaceuticals collaborates with research institutions and regulatory bodies to advance its programs. Its activities contribute to the field of neuro-oncology by addressing significant challenges in treating brain-related cancers.
CNS Pharmaceuticals, Inc. Stock Price Today: Live Overview
The price today is shaped by the session's trading range, as CNS Pharmaceuticals, Inc. trades at $2.3176. Prices have oscillated between $2.1524 and $2.4424, marking a daily change of -4.3433%.
FAQ: CNS Pharmaceuticals, Inc. (CNSP)
What is the current price of CNSP stock?
CNS Pharmaceuticals, Inc. is currently at $2.3176.
Does CNSP pay dividends?
CNS Pharmaceuticals, Inc. does not pay dividends.
Does CNSP have a formal corporate presence or regional headquarters in the UAE?
CNS Pharmaceuticals, Inc. operates in the UAE solely through partners and distributors without a direct office.
What is CNSP best known for?
The company is most famous for developing oncology drug candidates.
What assets are typically shown together with CNSP?
Commonly shown alongside CNSP: JinkoSolar, Evercore, Naturgy Energy Group, S.A.
Latest shares articles



